arrow_right
Pivotal Study Design
CLINICAL STUDY DESIGN
The BRAVE study is a prospective, multicenter clinical study enrolling patients for use in the development and clinical validation of Envisia classifier.

The study included patients undergoing clinical evaluation for new onset interstitial lung disease requiring tissue biopsy.
CONTACT A REP TO ORDER VERACYTE TESTING
Veracyte representatives are happy to assist you and to discuss how to integrate our tests into your practice.
First Name
Last Name
Email
Institution
Zip Code
Which Test Interests You?
More About You
Message
CONTACT REP
© 2019 Veracyte, Inc. All rights reserved.